Veritas In Silico Inc. (TYO:130A)

Japan · Delayed Price · Currency is JPY

436.00

+19.00 (4.56%)

Last updated: Jul 15, 2026, 1:03 PM JST

Revenue by Segment

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Drug Discovery Platform Business	91.14M	194.64M	360.36M	178.80M	59.33M
Drug Discovery Platform Business Growth	-53.18%	-45.99%	101.54%	201.37%	-
Total	91.14M	194.64M	360.36M	178.80M	59.33M
Total Growth	-53.18%	-45.99%	101.54%	201.37%	-

Revenue by Geography

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Japan	91.14M	194.64M	360.36M	178.80M	59.33M
Japan Growth	-53.18%	-45.99%	101.54%	201.37%	-
Total	91.14M	194.64M	360.36M	178.80M	59.33M
Total Growth	-53.18%	-45.99%	101.54%	201.37%	-